Table 1.
Clinicopathologic characteristics.
| Characteristic | n = 60 (%) |
|---|---|
| Age, median (range), years | 51.2 (18.3–74.8) |
| Male Female |
37 (62%) 23 (38%) |
| Smoking Status | |
| Current | 4 (8%) |
| Former | 13 (22%) |
| Non-smoker | 41 (71%) |
| Unknown | 2 (4%) |
| Pathology | |
| WHO I | 1 (2%) |
| WHO IIA | 10 (16%) |
| WHO IIB | 49 (82%) |
| Stage | |
| I | 2 (4%) |
| II | 11 (21%) |
| III | 19 (37%) |
| IVa | 12 (23%) |
| IVb | 7 (13%) |
| IVc | 1 (2%) |
| T | |
| T1 | 24 (40%) |
| T2 | 12 (20%) |
| T3 | 7 (12%) |
| T4 | 17 (28%) |
| N | |
| N0 | 4 (7%) |
| N1 | 22 (20%) |
| N2 | 26 (43%) |
| N3 | 1 (2%) |
| N3A | 5 (8%) |
| N3B | 2 (3%) |
| M | |
| M0 | 57 (95%) |
| M1 | 3 (5%) |
| Status | |
| Alive | 42 (70%) |
| Dead | 18 (30%) |
| Treatment | |
| Radiotherapy alone | 6 (10%) |
| Chemoradiotherapy | 54 (90%) |
| Local Failure | 4 (7%) |
| Regional Failure | 5 (8%) |
| Distant Failure | 8 (13%) |